Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Shoulder Innovations › CEO exercised or converted 89K SI derivative securities Insider trades
Why it stands out Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Sep 14, 2026
Reporting period Not applicable
Filed with the SEC Sep 15, 2026 CEO Option exercise
Context Classification option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue Footnote references an employee stock purchase plan
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0002070664-26-000006
Filed / recorded
Sep 15, 2026, 4:23 AM UTC
Added to OQRO Oct 7, 2026, 5:52 AM UTC
Data quality Verified: identifiers matched exactly
Issuer SHOULDER INNOVATIONS, INC.
Reporting person Robert Joseph Ball
Relationship Director, Officer
Officer title CEO & Executive Chairman
Table Non-derivative (Table I)
Transaction date Sep 14, 2026
Acquired / disposed Acquired (A)
Shares owned after 390,999
Footnotes from the filing Includes 1,748 shares of Common Stock acquired on June 30, 2026 pursuant to the Issuer's 2025 Employee Stock Purchase Plan.
Around the same time Insider filing
Traded Oct 5 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Oct 5 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Oct 5 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Jul 30, 2026 Insider 10% owner sold ~$660K of SI shares in the open market Jul 31, 2026 Insider 10% owner sold ~$455K of SI shares in the open market Aug 3, 2026 Insider 10% owner sold ~$244K of SI shares in the open market Aug 4, 2026 Insider · 2 days before results 10% owner sold ~$2.27M of SI shares in the open market Aug 5, 2026 Insider 10% owner sold ~$166K of SI shares in the open market Aug 6, 2026 Company filing · Form 8-K · Results Reported its results Aug 6, 2026 Insider 10% owner sold ~$47K of SI shares in the open market Aug 17, 2026 Insider Director sold ~$167K of SI shares in the open market Aug 18, 2026 Insider · 1 person Insiders: 2 sales (~$298K) Aug 20, 2026 Insider 10% owner sold ~$88K of SI shares in the open market Aug 21, 2026 Insider 10% owner sold ~$464K of SI shares in the open market Aug 24, 2026 Insider 10% owner sold ~$15K of SI shares in the open market Aug 26, 2026 Insider 10% owner sold ~$27K of SI shares in the open market Sep 8, 2026 FDA FDA device clearance: N22 Offset Humeral Head Sep 14, 2026 Insider CEO sold ~$188K of SI shares in the open market What came next Nov 5, 2026 Company filing · Form 8-K · Results Reported its results